Citation: Lingyu Hang, Chengying Shen, Baode Shen, Hailong Yuan. Insight into the in vivo fate of intravenous herpetrione amorphous nanosuspensions by aggregation-caused quenching probes[J]. Chinese Chemical Letters, ;2022, 33(11): 4948-4951. doi: 10.1016/j.cclet.2022.03.108 shu

Insight into the in vivo fate of intravenous herpetrione amorphous nanosuspensions by aggregation-caused quenching probes

Lingyu Hang ^{a, b, 1} ,
Chengying Shen ^{c, 1} ,
Baode Shen ^{b, *,} ,
Hailong Yuan ^{a, b, *,}

a.
Department of Pharmacy, Air Force Medical Center, PLA, Beijing 100142, China
b.
College of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, China
c.
Department of Pharmacy, Jiangxi Provincial People's Hospital, Nanchang 330006, China

shenbaode@163.com

yhlpharm@126.com

Received Date: 15 December 2021
Revised Date: 27 March 2022
Accepted Date: 29 March 2022
Available Online: 4 April 2022

Figures(5)

Intravenous nanosuspensions are attracted growing attention as a viable strategy for development of intravenous formulations of poorly water-soluble drugs. However, only few information about the biological fate of intravenous nanosuspensions is currently known, especially amorphous nanosuspensions are not reported yet. In this study, the in vivo fate of herpetrione (HPE) amorphous nanosuspensions following intravenous administration was explored by using an aggregation-caused quenching (ACQ) probe and HPLC methods. The ACQ probe is physically embedded into HPE nanoparticles via anti-solvent method to form HPE hybrid nanosuspensions (HPE-HNSs) for bioimaging. HPE-HNSs emit strong and stable fluorescence, but fluorescence quenches immediately upon the dissolution of HPE-HNSs, confirming the self-discrimination of HPE-HNSs. Following intravenous administration of HPE-HNSs, integral HPE-HNSs and HPE show similar degradation and biodistribution, with rapid clearance from blood circulation and obvious accumulation in liver and lung. Due to the slower dissolution and enhanced recognition by reticulo-endothelial system, 450 nm HPE-HNSs accumulate more in liver, lung and spleen than that of 200 nm HPE-HNSs. These results demonstrate that integral HPE-HNSs determine the in vivo performance of HPE-HNSs. This study provides insight into the in vivo fate of intravenous amorphous nanosuspensions.
- Amorphous nanosuspensions,
- Herpetrione,
- In vivo fate,
- Intravenous delivery,
- Aggregation-caused quenching
1. [1]
  S. Jacob, A.B. Nair, J. Shah, Biomater. Res. 24 (2020) 3. doi: 10.1186/s40824-020-0184-8
2. [2]
  D. Patel, S.S. Zode, A.K. Bansal, Int. J. Pharm. 586 (2020) 119555. doi: 10.1016/j.ijpharm.2020.119555
3. [3]
  Z.L. Wang, Z.W. Li, D. Zhang, L. Miao, G.H. Huang, Drug Deliv. 22 (2015) 79–85. doi: 10.3109/10717544.2013.871600
4. [4]
  Y. Lu, J.P. Qi, X. Dong, W. Zhao, W. Wu, Drug Discov. Today 22 (2017) 744–750. doi: 10.1016/j.drudis.2017.01.003
5. [5]
  N.P. Aditya, H.J. Yang, S. Kim, S. Ko, Colloids Surf. B: Biointerfaces 127 (2015) 114–121. doi: 10.1016/j.colsurfb.2015.01.027
6. [6]
  R.D. Bachu, P. Chowdhury, Z.H. Al-Saedi, P.K. Karla, S.H. Boddu, Pharmaceutics 10 (2018) 28. doi: 10.3390/pharmaceutics10010028
7. [7]
  V.K. Pawar, Y. Singh, J.G. Meher, S. Gupta, M.K. Chourasia, J. Control. Release 183 (2014) 51–66. doi: 10.1016/j.jconrel.2014.03.030
8. [8]
  Y. Lu, Y. Chen, R.A. Gemeinhart, W. Wu, T.L. Li, Nanomedicine 10 (2015) 2537–2552. doi: 10.2217/nnm.15.73
9. [9]
  L.L. Wang, J. Du, Y.Q. Zhou, Y.C. Wang, Nanomedicine 13 (2017) 455–469. doi: 10.1016/j.nano.2016.08.007
10. [10]
  A. Madni, M.A. Rahem, N. Tahir, Int. J. Pharm. 530 (2017) 326–345. doi: 10.1016/j.ijpharm.2017.07.065
11. [11]
  A. Tuomela, J. Hirvonen, L. Peltonen, Pharmaceutics 8 (2016) 16. doi: 10.3390/pharmaceutics8020016
12. [12]
  D. Dong, X. Wang, H. Wang, et al., Int. J. Nanomedicine 10 (2015) 2521–2535.
13. [13]
  C.P. Hollis, H.L. Weiss, M. Leggas, et al., J. Control. Release 172 (2013) 12–21. doi: 10.1016/j.jconrel.2013.06.039
14. [14]
  C.Y. Shen, Y.Q. Yang, B.D. Shen, et al., Nanoscale 10 (2017) 436–450.
15. [15]
  B.D. Shen, C.Y. Shen, W.F. Zhu, H.L. Yuan, Acta Pharm. Sin. B 11 (2021) 978–988. doi: 10.1016/j.apsb.2021.02.015
16. [16]
  T. Wang, J.P. Qi, N. Ding, et al., Int. J. Pharm. 546 (2018) 10–19. doi: 10.1016/j.ijpharm.2018.05.020
17. [17]
  T.T. Shi, Y.J. Lv, W.Z. Huang, et al., Int. J. Pharm. 588 (2020) 119737. doi: 10.1016/j.ijpharm.2020.119737
18. [18]
  Y.K. Xie, B.K. Shi, F. Xia, et al., J. Control. Release 270 (2018) 65–75. doi: 10.1016/j.jconrel.2017.11.046
19. [19]
  D.L. Liu, B. Wan, J.P. Qi, et al., Chin. Chem. Lett. 29 (2018) 1834–1838. doi: 10.1016/j.cclet.2018.11.015
20. [20]
  Y.Q. Yang, Y.J. Lv, C.Y. Shen, et al., Acta Pharm. Sin. B 11 (2021) 1056–1068. doi: 10.1016/j.apsb.2020.08.002
21. [21]
  H.S. He, L.T. Wang, Y.H. Ma, et al., J. Control. Release 327 (2020) 725–736. doi: 10.1016/j.jconrel.2020.09.024
22. [22]
  L. Zoya, H.S. He, L.T. Wang, et al., Chin. Chem. Lett. 32 (2021) 1545–1549. doi: 10.1016/j.cclet.2020.09.038
23. [23]
  J.P. Qi, X.W. Hu, X.C. Dong, et al., Adv. Drug. Deliv. Rev. 143 (2019) 206–225. doi: 10.1016/j.addr.2019.05.009
24. [24]
  H.S. He, S.F. Jiang, Y.C. Xie, et al., Nanoscale Horiz. 3 (2018) 397–407. doi: 10.1039/C8NH00010G
25. [25]
  F. Xia, W.F. Fan, S.F. Jiang, et al., ACS Appl. Mater. Interfaces 9 (2017) 21660–21672. doi: 10.1021/acsami.7b04916
26. [26]
  E. Ahmad, Y.H. Feng, J.P. Qi, et al., Nanoscale 9 (2017) 1174–1183. doi: 10.1039/C6NR07581A
27. [27]
  X.W. Hu, J. Zhang, Z. Yu, et al., Nanomedicine11 (2015) 1939–1948. doi: 10.1016/j.nano.2015.06.013
28. [28]
  J.F. Zhang, C.D. Corpstein, T.L. Li, Acta Pharm. Sin. B 11 (2021) 1021–1029. doi: 10.1016/j.apsb.2020.09.017
29. [29]
  J.J. Guo, P.F. Yue, J.L. Lv, et al., Int. J. Pharm. 441 (2013) 227–233. doi: 10.1016/j.ijpharm.2012.11.039
30. [30]
  B.D. Shen, C.Y. Shen, X.D. Yuan, et al., Eur. J. Pharm. Biopharm. 85 (2013) 1348–1356. doi: 10.1016/j.ejpb.2013.09.019
31. [31]
  T. Chen, C. Li, Y. Li, et al., Mol. Pharm. 13 (2016) 3864–3875. doi: 10.1021/acs.molpharmaceut.6b00644
32. [32]
  X.H. Wang, Y. Liu, C.Y. Shen, et al., J. Drug Deliv. Sci. Tec. 52 (2019) 778–783. doi: 10.1016/j.jddst.2019.05.005
33. [33]
  J.L. Yang, Z.R. Dong, W.J. Liu, et al., Chin. Chem. Lett. 29 (2020) 875–879.
34. [34]
  C.G. Park, Y.K. Kim, M.J. Kim, J. Control. Release 220 (2015) 180–188. doi: 10.1016/j.jconrel.2015.10.027
35. [35]
  G.P. Liu, D.R. Zhang, Y. Jiao, et al., Colloids Surf. B 102 (2013) 620–626. doi: 10.1016/j.colsurfb.2012.09.006
1. [1]
  Yuwen Zhu , Xiang Deng , Yan Wu , Baode Shen , Lingyu Hang , Yuye Xue , Hailong Yuan . Formation mechanism of herpetrione self-assembled nanoparticles based on pH-driven method. Chinese Chemical Letters, 2025, 36(1): 109733-. doi: 10.1016/j.cclet.2024.109733
2. [2]
  Lu Li , Suticha Chunta , Xianzi Zheng , Haisheng He , Wei Wu , Yi Lu . β-Lactoglobulin stabilized lipid nanoparticles enhance oral absorption of insulin by slowing down lipolysis. Chinese Chemical Letters, 2024, 35(4): 108662-. doi: 10.1016/j.cclet.2023.108662
3. [3]
  Wenhao Wang , Siyuan Peng , Zhengwei Huang , Xin Pan . Tuning amino/hydroxyl ratios of nanovesicles to manipulate protein corona-mediated in vivo fate. Chinese Chemical Letters, 2024, 35(11): 110134-. doi: 10.1016/j.cclet.2024.110134
4. [4]
  Liqing Chen , Zheming Zhang , Yanhong Liu , Chenfei Liu , Congcong Xiao , Liming Gong , Mingji Jin , Zhonggao Gao , Wei Huang . Systemically intravenous siRNA delivery into brain with a targeting and efficient polypeptide carrier and its evaluation on anti-glioma efficacy. Chinese Chemical Letters, 2025, 36(3): 110228-. doi: 10.1016/j.cclet.2024.110228
5. [5]
  Zihong Li , Jie Cheng , Ping Huang , Guoliang Wu , Weiying Lin . Activatable photoacoustic bioprobe for visual detection of aging in vivo. Chinese Chemical Letters, 2024, 35(4): 109153-. doi: 10.1016/j.cclet.2023.109153
6. [6]
  Shihong Wu , Ronghui Zhou , Hang Zhao , Peng Wu . Sonoafterglow luminescence for in vivo deep-tissue imaging. Chinese Chemical Letters, 2024, 35(10): 110026-. doi: 10.1016/j.cclet.2024.110026
7. [7]
  Makhloufi Zoulikha , Zhongjian Chen , Jun Wu , Wei He . Approved delivery strategies for biopharmaceuticals. Chinese Chemical Letters, 2025, 36(2): 110225-. doi: 10.1016/j.cclet.2024.110225
8. [8]
  Gongcheng Ma , Qihang Ding , Yuding Zhang , Yue Wang , Jingjing Xiang , Mingle Li , Qi Zhao , Saipeng Huang , Ping Gong , Jong Seung Kim . Palladium-free chemoselective probe for in vivo fluorescence imaging of carbon monoxide. Chinese Chemical Letters, 2024, 35(9): 109293-. doi: 10.1016/j.cclet.2023.109293
9. [9]
  Rui Deng , Wenjie Jiang , Tianqi Yu , Jiali Lu , Boyao Feng , Panagiotis Tsiakaras , Shibin Yin . Cycad-leaf-like crystalline-amorphous heterostructures for efficient urea oxidation-assisted water splitting. Chinese Journal of Structural Chemistry, 2024, 43(7): 100290-100290. doi: 10.1016/j.cjsc.2024.100290
10. [10]
  Yulong Liu , Haoran Lu , Tong Yang , Peng Cheng , Xu Han , Wenyan Liang . Catalytic applications of amorphous alloys in wastewater treatment: A review on mechanisms, recent trends, challenges and future directions. Chinese Chemical Letters, 2024, 35(10): 109492-. doi: 10.1016/j.cclet.2024.109492
11. [11]
  Ning DING , Siyu WANG , Shihua YU , Pengcheng XU , Dandan HAN , Dexin SHI , Chao ZHANG . Crystalline and amorphous metal sulfide composite electrode materials with long cycle life: Preparation and performance of hybrid capacitors. Chinese Journal of Inorganic Chemistry, 2024, 40(9): 1784-1794. doi: 10.11862/CJIC.20240146
12. [12]
  Jiajia Lv , Jie Gao , Hongyu Li , Zeli Yuan , Nan Dong . Rational design of hydroxytricyanopyrrole-based probes with high affinity and rapid visualization for amyloid-β aggregates in vitro and in vivo. Chinese Chemical Letters, 2024, 35(5): 108940-. doi: 10.1016/j.cclet.2023.108940
13. [13]
  Meiling Zhao , Yao Lu , Yutao Zhang , Haoyun Xue , Zhiqian Guo . Ultra-high signal-to-noise ratio near-infrared chemiluminescent probe for in vivo sensing singlet oxygen. Chinese Chemical Letters, 2025, 36(5): 110105-. doi: 10.1016/j.cclet.2024.110105
14. [14]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
15. [15]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335
16. [16]
  Ke Zhang , Yajing Wei , Linhua Xie , Sha Kang , Fei Li , Chuanyi Wang . Amorphous titanium carbide on N-defective g-C₃N₅ for high-efficiency photocatalytic NO removal. Chinese Chemical Letters, 2025, 36(3): 110086-. doi: 10.1016/j.cclet.2024.110086
17. [17]
  Qin Yu , Haisheng He , Jianping Qi , Yi Lu , Wei Wu . Oral delivery of insulin by barbed microneedles actuated by intestinal peristalsis. Chinese Chemical Letters, 2024, 35(9): 109888-. doi: 10.1016/j.cclet.2024.109888
18. [18]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420
19. [19]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
20. [20]
  Weiyu Chen , Zenghui Li , Chenguang Zhao , Lisha Zha , Junfeng Shi , Dan Yuan . Enzyme-modulate conformational changes in amphiphile peptide for selectively cell delivery. Chinese Chemical Letters, 2024, 35(12): 109628-. doi: 10.1016/j.cclet.2024.109628

Get Citation

PDF

XML

Metrics

PDF Downloads(7)
Abstract views(727)
HTML views(65)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142